Our Certifications
Quality and compliance credentials supporting VitaMFG manufacturing.
Why Choose VitaMFG for Probiotic Prebiotic Gummies?
- Named strain required instead of species-only probiotic labeling
- CFU target defined at expiration rather than only at manufacture
- Stability-based overage supported by data, not arbitrary excess addition
- One-gram fiber target with documented analytical fiber contribution
- Low-temperature addition, low-water-activity development and moisture-barrier review
- OEM/ODM support from strain qualification through pilot, stability and scale-up
A Probiotic Gummy Built around Expiry-Date Viability
This Wave 3 concept targets 5 billion CFU of a named, deposited Bacillus coagulans strain at the end of shelf life, together with 1,000 mg of acacia fiber or inulin in two approximately 3.0–3.5 g gummies per day. Mixed Berry and Peach are the initial flavor directions.
The page does not treat all Bacillus coagulans strains as interchangeable or promise that a high input count will survive processing and storage. Strain identity, supplier potency, carrier system, heat exposure, water activity, oxygen and moisture transmission, packaging and transport conditions must be evaluated as one system. The fiber source also remains open until its analytical contribution, tolerance, texture and label treatment are confirmed. “Shelf stable,” “5 billion CFU at expiry” and “synbiotic” become finished-product claims only when their respective stability, formulation and substantiation requirements are met. Final strain, overage, fiber, flavor, base, storage directions, warnings and label values follow approved data.
Probiotic Prebiotic Gummy Product Directions
Use the current two-active baseline or adapt the strain, fiber and market position after supplier, evidence, tolerance and stability review.
Bacillus coagulans Probiotic Gummies
A spore-forming probiotic route designed for gummy feasibility, with the exact strain and expiry-date CFU target shown clearly.
Probiotic and Prebiotic Fiber Gummies
The complete concept combines a named bacterial strain with a one-gram acacia-fiber or inulin development target.
Acacia Fiber Probiotic Gummies
A fiber route that can be evaluated for analytical contribution, mouthfeel, process compatibility and adult tolerance.
Inulin Probiotic Gummies
An alternative route for brands that want inulin, subject to serving-level tolerance, texture, water activity and label review.
Peach Probiotic Gummies
A familiar flavor direction for adult wellness brands seeking a soft, approachable daily gummy experience.
Private Label Probiotic Gummies
An OEM/ODM route covering strain selection, fiber, CFU target, flavor, packaging, testing, stability, claims and commercialization.
Product Advantages for Probiotic Prebiotic Gummies
This concept gives brands four verifiable product facts instead of relying on a generic “billions of probiotics” headline.
5 Billion CFU at Expiry
The target applies to the end of the proposed shelf life and must be supported by real-time stability in commercial packaging.
Named Probiotic Strain
The final label and technical file identify the selected deposited strain, because probiotic evidence is strain- and use-specific.
1 g Fiber Target
Acacia fiber or inulin is included at a meaningful formulation level, with actual dietary-fiber contribution confirmed analytically.
Two Gummies Daily
Two approximately 3.0–3.5 g gummies deliver the complete development target for adults who prefer an alternative to capsules.
Protect Live Count through the Expiration Date
Spore-forming Bacillus coagulans is a more gummy-suitable starting point, but still requires process and shelf-life validation. VitaMFG reviews supplier potency, carriers, premixing, addition temperature, hold time, depositing, drying, water activity and oxygen and moisture exposure. Defined batch samples establish initial count and uniformity. Accelerated work guides development; real-time testing in the proposed package supports the expiration-date CFU target. Overage follows observed loss and approved shelf life.
Match Fiber, Texture and Tolerance
One gram of fiber affects more than the ingredient list. Acacia fiber and inulin differ in solubility, solids contribution, water binding, texture and individual digestive tolerance. Each route is assessed in the complete two-gummy serving, not only in the kettle. Pectin level, pH, water activity, depositing behavior, drying, chew, sticking and flavor are closed alongside the fiber choice. The finished-product analytical plan must also confirm how much dietary fiber can be declared. If the probiotic-plus-fiber combination lacks the evidence required for a synbiotic claim, the page should simply call it probiotic and prebiotic fiber.
Process and Stability Control for Live-Culture Gummies
VitaMFG is an engineering-led functional gummy manufacturer operating under an NSF/ANSI 455-2 GMP-certified quality system. Under standard conditions, commercial capacity can reach 8–10 metric tons per day, subject to formula, gummy weight, packaging and scheduling.
For probiotic projects, R&D and quality work from the exact strain, supplier potency and target CFU date—not a species name alone. Records connect ingredient lot, premixing, temperature, hold time, drying, pH, water activity and packaging. Initial viability, distribution, microbial quality, sensory results and real-time stability form the transfer path to pilot and production. Batch records and retained samples support repeatability. A high initial result is not proof of shelf-life performance.
Probiotic Gummy Projects for Different Markets
The platform can support several commercial routes while keeping strain, expiry-date CFU and storage conditions visible.
Digestive Wellness Brands
Build an adult daily-use product around one named strain, a transparent expiration-date target and a simple two-gummy serving. Any digestive structure/function wording must be tied to the selected strain, dose, finished formula and evidence rather than borrowed from another Bacillus coagulans strain or a capsule study.
Amazon and DTC Supplement Brands
Use verification as the trust story: show the strain code, define whether CFU applies at manufacture or expiry, state the fiber amount and explain storage. VitaMFG can align supplier specifications, stability plans, Supplement Facts, customer-service answers and batch documentation so page language and technical records do not contradict each other.
Adult Gummy Vitamin Lines
Offer Mixed Berry or Peach as a capsule alternative while keeping texture and bottle performance central. Consumers notice hard chew, sticking and flavor before they can judge a long-term routine. The complete serving and packaged product must therefore be evaluated for chew, aftertaste, moisture pickup and clumping throughout stability.
Retail Private Label Programs
Start with intended user, strain ownership and licensing, CFU target, fiber choice, shelf life, storage, bottle count and retailer requirements. High-barrier bottles or blisters and desiccants are selected through package and transport work. A no-refrigeration or shelf-stable message is used only after the approved package supports it.
What Consumers Expect from Probiotic Gummies
Public category reviews show that taste supports daily use, but texture and bottle sticking can quickly undermine the experience. These are third-party reviews of other products, not reviews of this concept or VitaMFG and not evidence of probiotic efficacy.
Probiotic Prebiotic Gummies Specifications
| Parameter | Development Baseline | Customization / Notes |
|---|---|---|
| Product Type | Probiotic + Prebiotic Fiber Gummies | Private Label / OEM / ODM |
| Development Stage | Product 13, Wave 3 feasibility gate | U.S.-first R&D design target; not a production formula |
| Intended User | Adults seeking daily microbiome-support nutrition in gummy form | Final age, health status and warning language require label review |
| Serving Size | 2 gummies per day | One complete serving |
| Target Gummy Weight | Approx. 3.0–3.5 g per gummy | Approx. 6–7 g total serving weight |
| Probiotic Species | Bacillus coagulans | Final named, deposited strain must be selected; strain identity and legal naming follow supplier and market review |
| Viable Count | Target: 5 billion CFU per serving at expiry | Initial addition and overage determined from process recovery and stability; higher CFU is not automatically better |
| Prebiotic-Fiber Route | Target: 1,000 mg acacia fiber or inulin per serving | Final source follows analytical contribution, tolerance, sensory and process review |
| Flavor | Mixed Berry or Peach first-trial directions | Center flavor plus one alternative recommended |
| Gummy Base | Recommended low-water-activity pectin development system | Pectin, gelatin-free, vegan, sugar-free and other dietary claims require final formula confirmation |
| Process Focus | Controlled premix / low-temperature late addition / short hold / depositing / drying | Exact temperature and time limits follow strain and equipment trials |
| Packaging | High-barrier bottle or blister plus desiccant proposed | Final WVTR/OTR, desiccant, light barrier and transport limits follow stability work |
| Finished-Product Testing | Strain identity / viable count / uniformity / objectionable organisms / microbiology / heavy metals / applicable contaminants / fiber where applicable / physical indicators | Methods, sampling plan and limits require laboratory and quality approval |
| Stability Focus | CFU / strain identity where applicable / moisture / water activity / texture / syneresis / sticking / flavor / package integrity | Initial, accelerated and real-time time points in proposed commercial packaging |
| Shelf-Stable Claim | Not yet confirmed | Storage temperature, humidity and no-refrigeration wording follow complete stability data |
| Synbiotic Claim | Not automatically confirmed by combining a probiotic and fiber | Requires the selected components and combined formulation to meet the applicable evidence definition |
| Claims Boundary | Evidence-supported structure/function wording only | No disease treatment, prevention, cure or strain-borrowed claims |
| Safety Boundary | Severely immunocompromised or seriously ill consumers should seek professional guidance | Final warning follows strain, intended user and destination-market review |
| Project Status | Conditional development, priority A | P0 strain and source closure → P1 feasibility → P2 analysis and stability → P3 pilot and commercial review |
| MOQ & Timeline | Confirmed after feasibility review | Depends on strain, fiber, formula, testing, packaging, shelf life and volume |
Start Your Supplement Manufacturing Project
Tell us what you want to manufacture — including dosage form, formulation requirements, packaging, target market, and expected volume. We'll review your project and recommend the next steps.
Share your project details — our team will review feasibility, process alignment, and next steps.
